Is it possible to reverse the endothelial dysfunction in pulmonary arterial hypertension? Editorial comment

被引：11
|
作者：
Barst, Robyn
机构：
[1] Columbia Univ, New York, NY 10032 USA
[2] Acteltion, New York, NY USA
[3] Biogen Idec, New York, NY USA
[4] Encysive, New York, NY USA
[5] Gilead Sci Inc, New York, NY USA
[6] INO, New York, NY USA
[7] Lilly, New York, NY USA
[8] LungRx, New York, NY USA
[9] Medtronics, New York, NY USA
[10] MondoBiotech, New York, NY USA
[11] Novartis, New York, NY USA
[12] Pfizer, New York, NY USA
[13] Unite Therapeut, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 49卷 / 14期
关键词：
D O I：
10.1016/j.jacc.2007.01.054
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1572 / 1574
页数：3
相关论文
共 50 条
  • [1] Endothelial dysfunction in pulmonary arterial hypertension (PAH)
    Thambiayya, Kalidasan
    [J]. FASEB JOURNAL, 2015, 29
  • [2] Peripheral arterial stiffness and endothelial dysfunction in pulmonary arterial hypertension
    Chamorro, Nuria
    Del Pozo, Roberto
    Garcia-Lucio, Jessica
    Torralba, Yolanda
    Blanco, Isabel
    Lopez-Meseguer, Manuel
    Ribas, Jesus
    Rodriguez, Diego
    Albert Barbera, Joan
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [3] Peripheral endothelial dysfunction in patients with pulmonary arterial hypertension
    Peled, Nir
    Bendayan, Daniele
    Shitrit, David
    Fox, Ben
    Yehoshua, Liora
    Kramer, Mordechai R.
    [J]. RESPIRATORY MEDICINE, 2008, 102 (12) : 1791 - 1796
  • [4] Evidence of Dysfunction of Endothelial Progenitors in Pulmonary Arterial Hypertension
    Toshner, Mark
    Voswinckel, Robert
    Southwood, Mark
    Al-Lamki, Rafia
    Howard, Luke S. G.
    Marchesan, Denis
    Yang, Jun
    Suntharalingam, Jay
    Soon, Elaine
    Exley, Andrew
    Stewart, Susan
    Hecker, Markus
    Zhu, Zhenping
    Gehling, Ursula
    Seeger, Werner
    Pepke-Zaba, Joanna
    Morrell, Nicholas W.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 180 (08) : 780 - 787
  • [5] Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension
    Good, Robert B.
    Gilbane, Adrian J.
    Trinder, Sarah L.
    Denton, Christopher P.
    Coghlan, Gerry
    Abraham, David J.
    Holmes, Alan M.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (07): : 1850 - 1858
  • [6] Endothelial cell clonality, heterogeneity and dysfunction in pulmonary arterial hypertension
    Newcomb, Geoffrey
    Farkas, Laszlo
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [7] Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension
    Hudson, Jaylen
    Farkas, Laszlo
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [8] Nitric Oxide Deficiency and Endothelial Dysfunction in Pulmonary Arterial Hypertension
    Klinger, James R.
    Abman, Steven H.
    Gladwin, Mark T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (06) : 639 - 646
  • [9] Endothelial dysfunction and arterial hypertension
    Zhurova, V. M.
    Podpalov, V. P.
    Solodkov, A. P.
    [J]. JOURNAL OF HYPERTENSION, 2006, 24 : S309 - S309
  • [10] Endothelial dysfunction in arterial hypertension
    F Contreras
    M Rivera
    J Vásquez
    MA De la Parte
    M Velasco
    [J]. Journal of Human Hypertension, 2000, 14 : S20 - S25
12345